Table 1

 Comparison of baseline characteristics of responders and non-responders to inhaled bronchodilators at the time of screening (n = 1622)

VariablesResponders (n = 787)Non-responders (n = 835)OR (95% CI)*, p value
*Odds ratio and 95% CI reported for categorical variables. For continuous variables only p values are reported.
Demographic indicators
    Male534 (67.9%)534 (64.0%)0.84 (0.68 to 1.04), 0.11
    Age 1–11 months385 (48.9%)424 (50.8%)1.08 (0.88 to 1.32), 0.48
        Median (IQR)6.0 (4.0–8.0)5.0 (4.0–8.0)
    Age 12–59 months402 (51.1%)411 (49.2%)
        Median (IQR)25.5 (18.0–37.0)22.0 (15.0–34.0)
History and signs
    Fever343 (43.6%)691 (82.8%)6.48 (5.11 to 8.23), <0.00001
    Difficult breathing766 (97.3%)824 (98.7%)2.46 (0.95 to 6.62), 0.06
    Duration of illness
        Up to 2 days465 (59.1%)437 (52.3%)
         Median (IQR)2.0 (1.0–2.0)2.0 (1.0–2.0)
        More than 2 days322 (40.9%)398 (47.7%)1.32 (1.08 to 1.61), 0.01
         Median (IQR)3.0 (3.0–4.0)3.0 (3.0–5.0)
No past history of wheezing episode331 (42.1%)381 (45.6%)1.16 (0.95 to 1.41), 0.16
No family history of wheeze459 (58.3%)506 (60.6%)1.10 (0.90 to 1.35), 0.36
Presence of audible wheeze205 (26.0%)390 (46.7%)2.49 (2.01 to 3.08), <0.00001
Actual temperature (in °F)
    Up to 100°F762 (96.8%)689 (82.5%)
        Median (IQR)98.6 (98.6–98.6)99.0 (98.6–99.0)
    More than 100°F25 (3.2%)146 (17.5%)6.46 (4.10 to 10.2), <0.00001
        Median (IQR)100.8 (100.4–101.7)101.0 (100.2–101.2)
Weight for age Z score
        Median (IQR)−0.95 (−1.6 to −0.22)−0.95 (−1.7 to −0.18)0.69
Height for age Z score
        Median (IQR)−0.52 (−1.3 to 0.16)−0.66 (−1.4 to 8.0)0.38
ARI classification
        Non-severe pneumonia with wheeze621 (78.9%)383 (45.9%)
        Severe pneumonia (lower chest indrawing) with wheeze166 (21.1%)452 (54.1%)4.41 (3.53 to 5.53), <0.0001